Exciting news in Scleroderma land! :) A small "proof-of-principle" study published in the February issue of Rheumatology showed exciting preliminary results. Patients who received one year of rituximab treatment (a monoclonal antibody used for some cancer and autoimmune disease treatments) had significantly better lung function than control patients. Check out this link for more information:
http://www.medpagetoday.com/Rheumatology/GeneralRheumatology/18352
It's always exciting to see that research is being done on this nasty ol' disease, and it's because of people like you who support research that we see progress being made. Thanks!
Speaking of progress, I am heading to Chicago for my check-up tomorrow. My pain has been somewhat less this week, and I'm excited to get more good news. Wish me luck!
This drug really does look interesting. Is there any chance you could begin treatment with this if the cardiac news is not good for now? It seems like a good idea...
ReplyDelete